NCT07621536Completed
Diagnostic Accuracy of Eus Fnb in Difficult to Reach Lesions
Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Biopsy in Assessing "Difficult-to-reach" Abdominal Lesions: an Observational, Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
The present study aims at comprehensively assessing the diagnostic performance and safety profile of EUS-FNB as a primary diagnostic tool for suspected malignancies in anatomically complex or deeply situated regions, including the duodeno-jejunal, and hepatic hilar areas. By focusing on lesions that are challenging to reach due to their intricate anatomy or profound depth, investigators seek to provide valuable insights into the potential role of EUS-FNB in enhancing diagnostic accuracy and safety in these complex clinical scenarios.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 131 (actual)
- First submitted
- 25 May 2026
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07621536
What you commit to
- Study type: Observational
- Participants enrolled: 131
- From 1 Oct 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age less than 18 years old;
Other
- Patient unable to sign the informed consent.
Who the study is looking for
- age ≥ 18 years;
- patients with one or multiple lesions adjacent to the distal duodenum, or the proximal jejunum, or the hepatic hilum that underwent EUS in our Institution over the past 10 years;
- Patients monitored for at least 6 months after EUS-FNB or until death (follow-up less than 6 months);
- Available data;
- Written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario A. Gemelli IRCCS Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.